{"id":"W4406870066","doi":"10.1200/jco.2025.43.4_suppl.534","title":"Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two electronic medical record (EMR) databases.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Tremelimumab; Medicine; Durvalumab; Hepatocellular carcinoma; Internal medicine; Database; Oncology; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004082032,0.0002798191,0.002769276,0.0002803305,0.0000702565,0.000007829322,0.0005727572,0.0003107167,0.0001345385],"category_scores_gemma":[0.01589952,0.0001810844,0.0009620503,0.0004842856,0.0005470825,0.0001577036,0.0002088378,0.0004274096,4.816487e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005346017,"about_ca_system_score_gemma":0.002397167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002719257,"about_ca_topic_score_gemma":0.001105254,"domain_scores_codex":[0.9923257,0.001129384,0.005298836,0.0003126439,0.000518611,0.0004148265],"domain_scores_gemma":[0.9819474,0.01133192,0.005079967,0.0006971855,0.0007718552,0.0001717079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03887804,0.05675644,0.4810975,0.005411703,0.006639892,0.0003366045,0.0008400309,0.00007929156,0.2430106,0.1038242,0.002051012,0.06107465],"study_design_scores_gemma":[0.08452476,0.07475548,0.04667355,0.008234911,0.01118253,0.0004408527,0.0002503956,0.09876362,0.4916118,0.1268927,0.05526693,0.001402504],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866685,0.00009741409,0.01005068,0.001543164,0.0006940542,0.0007608298,0.00007267065,0.000009415975,0.0001033261],"genre_scores_gemma":[0.9895554,0.0003893209,0.009248994,0.0001391096,0.0003073986,0.00001359083,0.00002126599,0.00003290911,0.0002920325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.434424,"threshold_uncertainty_score":0.99239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2710967135358192,"score_gpt":0.4564556357622581,"score_spread":0.1853589222264389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}